Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factor adapted treatment of Hodgkin's lymphoma: strategies and perspectives.
Loeffler M, Pfreundschuh M, Rühl U, Hiller E, Gerhartz H, Roloff R, Adler M, Schoppe W, Hagen-Aukamp U, Schmitt G, et al. Loeffler M, et al. Among authors: gerhartz h. Recent Results Cancer Res. 1989;117:142-62. doi: 10.1007/978-3-642-83781-4_15. Recent Results Cancer Res. 1989. PMID: 2690225 Clinical Trial.
Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.
Diehl V, Pfreundschuh M, Löffler M, Rühl U, Hiller E, Gerhartz H, Kirchner H. Diehl V, et al. Among authors: gerhartz h. J Cancer Res Clin Oncol. 1990;116(1):106-8. doi: 10.1007/BF01612650. J Cancer Res Clin Oncol. 1990. PMID: 1690208 Clinical Trial. No abstract available.
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.
Diehl V, Pfreundschuh M, Löffler M, Rühl U, Hiller E, Gerhartz H, Wilmanns W, Kirchner H, Schoppe W, Petsch S, et al. Diehl V, et al. Among authors: gerhartz h. Med Oncol Tumor Pharmacother. 1989;6(2):155-62. doi: 10.1007/BF02985239. Med Oncol Tumor Pharmacother. 1989. PMID: 2473363 Clinical Trial.
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Fuchs R, Löffler M, Pfreundschuh M, Dölken G, Gerhartz H, Hagen-Aukamp U, Hiller E, Petsch S, Pflüger KH, Rühl U, et al. Fuchs R, et al. Among authors: gerhartz h. Leuk Lymphoma. 1994 Jun;14(1-2):79-89. doi: 10.3109/10428199409049653. Leuk Lymphoma. 1994. PMID: 7522721 Clinical Trial.
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Loeffler M, Diehl V, Pfreundschuh M, Rühl U, Hasenclever D, Nisters-Backes H, Sieber M, Tesch H, Franklin J, Geilen W, Bartels H, Cartoni C, Dölken G, Enzian J, Fuchs R, Gassmann W, Gerhartz H, Hagen-Aukamp U, Hiller E, Hinkelbein H, Hinterberger W, Kirchner H, Koch P, Krüger B, Schwarze EW, et al. Loeffler M, et al. Among authors: gerhartz h. J Clin Oncol. 1997 Jun;15(6):2275-87. doi: 10.1200/JCO.1997.15.6.2275. J Clin Oncol. 1997. PMID: 9196141 Clinical Trial.
188 results